(NP (NP (NN Induction)) (PP (IN of) (NP-COOD (NP (NN tyrosine) (NN phosphorylation)) (CC and) (NP (NN T-cell) (NN activation)))) (PP (IN by) (NP (NP (NN vanadate) (NN peroxide)) (, ,) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN protein) (NN tyrosine) (NNS phosphatases)))))) (. .))
(S (NP-SBJ (NP (JJ Rapid) (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (JJ key) (JJ cellular) (NNS proteins)))) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ crucial) (NN event)) (PP (IN in) (NP (NP (DT the) (NN transduction)) (PP (IN of) (NP (NN activation) (NNS signals))) (PP (TO to) (NP (NNS T-lymphocytes))))))) (. .))
(S (NP-SBJ-35 (NP (DT The) (JJ regulatory) (NN role)) (PP (IN of) (NP (NP (NN protein) (NN tyrosine) (NNS phosphatases)) (PRN (-LRB- -LRB-) (NP (NNS PTPases)) (-RRB- -RRB-)))) (PP (IN in) (NP (DT this) (NN process)))) (VP (VBD was) (VP (VBN explored) (NP (-NONE- *-35)) (PP (IN by) (S (NP-SBJ (-NONE- *)) (VP (VBG studying) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (DT a) (JJ powerful) (NN PTPase) (NN inhibitor)) (, ,) (NP (NP (NN vanadate) (NN peroxide)) (PRN (-LRB- -LRB-) (NP (NN pervanadate)) (-RRB- -RRB-))) (, ,))) (PP (IN on) (NP (NP (DT the) (NN activation) (NN cascade)) (PP (IN of) (NP (NN Jurkat) (JJ human) (JJ leukaemic) (NNS T-cells))))))))))) (. .))
(S (NP-SBJ (NN Pervanadate)) (VP (VBD induced) (NP-COOD (NP (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN tyrosine) (NNS kinases) (NP-COOD (NP (NN lck)) (CC and) (NP (NN fyn)))))) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 4-) (CC and) (JJ 3-fold))) (ADVP (RB respectively))) (-RRB- -RRB-))) (CC and) (NP (NP (DT a) (JJ dramatic) (NN increase)) (PP (IN in) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NP (JJ cellular) (NNS proteins)) (, ,) (NP (RB notably) (NN phospholipase) (NN C) (NN gamma) (CD 1))))))))) (. .))
(S (PP-TMP (IN After) (NP (DT this) (NN event))) (, ,) (NP-SBJ (PRP we)) (VP (VBD observed) (NP (NP (DT a) (NN rise)) (PP (IN in) (NP (JJ intracellular) (NN Ca2+) (NN concentration))) (, ,) (VP (VBG corresponding) (PP (TO to) (NP (DT an) (NN influx)))))) (. .))
(S (NP-SBJ-36 (DT This) (NN effect)) (VP-COOD (VP (VBD required) (NP (NP (NN surface) (NN expression)) (PP (IN of) (NP (DT the) (NN CD45) (NN PTPase))))) (CC and) (VP (VBD was) (RB not) (VP (VBN observed) (NP (-NONE- *-36)) (PP (IN in) (NP (NP (JJ CD45-deficient) (NNS variants)) (PP (IN of) (NP (NN Jurkat) (NNS cells)))))))) (. .))
(S-COOD (S (PP (IN In) (NP (DT the) (JJ CD45-negative) (NN variant))) (, ,) (NP-SBJ-37 (NP (DT the) (NN effect)) (PP (IN of) (NP (NN pervanadate))) (PP (IN on) (NP (NN tyrosine) (NN phosphorylation)))) (VP (VBD was) (ADVP (RB globally)) (VP (VBN decreased) (NP (-NONE- *-37))))) (CC and) (S (NP-SBJ (DT some) (VBN phosphorylated) (NNS substrates)) (VP (VBD were) (ADVP (RB specifically)) (ADJP-PRD (JJ missing)))) (. .))
(S (NP-SBJ (NN Pervanadate)) (ADVP (RB also)) (VP (VBD stimulated) (NP-COOD (NP (NP (NN transcription)) (PP (IN of) (NP (DT the) (NN c-fos) (NN gene)))) (CC and) (NP (NP (NN accumulation)) (PP (IN of) (NP (PRP$ its) (NN mRNA)))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ several) (JJ other) (NNS hallmarks)) (PP (IN of) (NP (NN T-lymphocyte) (NN activation))) (PP (JJ such) (IN as) (NP (NP (NN surface) (NN expression)) (PP (IN of) (NP-COOD (NP (DT the) (NN CD69) (NN antigen)) (CC and) (NP (NP (DT the) (NN interleukin) (CD 2) (NN receptor) (NN alpha-chain)) (PRN (-LRB- -LRB-) (NP (NN CD25)) (-RRB- -RRB-)))))))))) (. .))
(S (NP-SBJ-38 (NN Pervanadate)) (VP (VBD synergized) (PP (IN with) (NP (NP (NNS signals)) (VP (VBN delivered) (NP (-NONE- *)) (PP-COOD (PP (IN by) (NP-LGS (NN T-cell) (NN antigen) (NN receptor) (NN engagement))) (CC or) (PP (IN by) (NP-LGS (DT a) (NN phorbol) (NN ester))))))) (S (NP-SBJ (-NONE- *-38)) (VP (TO to) (VP (VB induce) (NP (NN interleukin) (CD 2) (NN production)))))) (. .))
(S (NP-SBJ (NN Pervanadate)) (VP (VBD activated) (NP (NN NF-kappa) (NN B)) (, ,) (SBAR (IN as) (S (NP-SBJ-39 (-NONE- *)) (VP (VBN shown) (NP (-NONE- *-39)) (PP (IN by) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (JJ DNA-binding) (NN activity)) (PP (IN of) (NP (DT this) (NN transcription) (NN factor))))))))))) (. .))
(S (NP-SBJ (PRP We)) (ADVP (RB thus)) (VP (VBP conclude) (SBAR (IN that) (S (NP-SBJ (NNS PTPases)) (VP (VBP play) (NP (DT a) (JJ crucial) (NN role)) (PP (IN in) (NP (NP (DT the) (JJ negative) (NN regulation)) (PP (IN of) (NP (NP (NN signal) (NN transduction)) (VP (VBG culminating) (PP (IN in) (NP (NN T-lymphocyte) (NN activation)))))))))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (NP-SBJ (NP (NN induction)) (PP (IN of) (NP (NN tyrosine) (NN phosphorylation)))) (VP (VBZ appears) (ADJP-PRD (JJ sufficient) (ADVP (FW per) (FW se)) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB initiate) (NP (DT a) (JJ complete) (NN activation) (NN programme))))))) (. .))
